Amaranthine is a venture capital firm that focuses on early-stage (Seed and Series A) investments in technology sectors such as AI, Fintech, Blockchain, Enterprise Applications, and Enterprise Infrastructure. Their strategy involves a hands-on approach to foster strategic partnerships, identifying disruptive innovations with a commitment to long-term value creation.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (75% of deals). Average disclosed round size is $14.0M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$50M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Black Crow AI | Series A | $25M | Mar 2022 |
 Beam | Series A | $9.5M | Feb 2021 |
| Beam | Seed | $3.5M | Oct 2020 |
 Huckleberry | Series A | $18M | Dec 2019 |
Top Co-Investors
Spark Capital2 shared
Alven2 shared
Tiny1 shared
Tiny VC1 shared
Primary Venture Partners1 shared
Bloomberg Beta1 shared
Canvas Ventures1 shared
Imaginary Ventures1 shared
Interlock Partners1 shared
Left Lane Capital1 shared
Good Friends1 shared
Interplay Ventures1 shared
Uncork Capital1 shared
Tribe1 shared
Crosslink Capital1 shared
Last updated: 4 May 2026